A detailed history of Weatherly Asset Management L. P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Weatherly Asset Management L. P. holds 10,010 shares of ABBV stock, worth $1.65 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,010
Previous 8,858 13.01%
Holding current value
$1.65 Million
Previous $1.52 Million 30.09%
% of portfolio
0.17%
Previous 0.14%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$163.84 - $199.33 $188,743 - $229,628
1,152 Added 13.01%
10,010 $1.98 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $87,765 - $102,490
-567 Reduced 6.02%
8,858 $1.52 Million
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $12,796 - $14,412
-93 Reduced 0.98%
9,425 $1.46 Million
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $34,982 - $43,533
264 Added 2.85%
9,518 $1.28 Million
Q4 2022

Jan 10, 2023

BUY
$138.31 - $165.87 $1,383 - $1,658
10 Added 0.11%
9,254 $0
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $10,334 - $11,852
-77 Reduced 0.83%
9,244 $1.24 Million
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $27,524 - $34,992
-200 Reduced 2.1%
9,321 $1.43 Million
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $11,086 - $13,755
84 Added 0.89%
9,521 $1.54 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $1,578 - $1,758
-15 Reduced 0.16%
9,437 $1.06 Million
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $2,147 - $2,520
-25 Reduced 0.26%
9,452 $828,000
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $104,185 - $139,415
1,420 Added 17.62%
9,477 $930,000
Q1 2020

May 01, 2020

SELL
$64.5 - $97.79 $838 - $1,271
-13 Reduced 0.16%
8,057 $614,000
Q4 2019

Jan 23, 2020

SELL
$72.13 - $90.25 $5,554 - $6,949
-77 Reduced 0.95%
8,070 $715,000
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $10,706 - $12,872
-170 Reduced 2.04%
8,147 $617,000
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $9,920 - $12,680
151 Added 1.85%
8,317 $605,000
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $37,490 - $44,123
-486 Reduced 5.62%
8,166 $658,000
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $12,066 - $14,881
-155 Reduced 1.76%
8,652 $798,000
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $31,118 - $34,594
-350 Reduced 3.82%
8,807 $833,000
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $213,187 - $285,477
-2,317 Reduced 20.19%
9,157 $867,000
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $4,657 - $5,106
-52 Reduced 0.45%
11,474 $1.11 Million
Q3 2017

Oct 20, 2017

BUY
$69.85 - $89.22 $805,091 - $1.03 Million
11,526
11,526 $1.02 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Weatherly Asset Management L. P. Portfolio

Follow Weatherly Asset Management L. P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weatherly Asset Management L. P., based on Form 13F filings with the SEC.

News

Stay updated on Weatherly Asset Management L. P. with notifications on news.